The Application of Bacterial Outer Membrane Vesicles in Tumor Treatment
10.16476/j.pibb.2023.0102
- VernacularTitle:细菌外膜囊泡应用于肿瘤治疗
- Author:
Yun-Feng WANG
1
;
Wan-Ru ZHUANG
1
;
Xian-Bin MA
1
;
Wei-Dong NIE
1
;
Hai-Yan XIE
1
Author Information
1. School of Life Science, Beijing Institute of Technology, Beijing 100081, China
- Publication Type:Journal Article
- Keywords:
bacterial adventitial vesicles;
tumor therapy;
delivery vector;
tumor vaccine
- From:
Progress in Biochemistry and Biophysics
2024;51(2):309-327
- CountryChina
- Language:Chinese
-
Abstract:
Outer membrane vesicles (OMVs) are nanoscale vesicles secreted by Gram-negative bacteria. As a unique bacterial secretion, OMV secretion can help bacteria maintain the outer membrane stability or remove harmful substances. Studies have shown that local separation of outer membrane and peptidoglycan layers led by abnormalities in outer membrane protein function, abnormal structure or excessive accumulation of LPS, and erroneous accumulation of phospholipids in the outer leaflet, which can all lead to bacterial outer membrane protrusion and eventually bud formation of OMVs. Since OMVs are mainly composed of bacterial outer membrane and periplasmic components, the pathogen associated molecular patterns (PAMPs) on their surface can trigger strong immune responses. For example, OMVs can recruit and activate neutrophils, polarize macrophages to secrete large amounts of inflammatory factors. More importantly, OMVs can act as adjuvants to induce dendritic cell (DC) maturation to enhance adaptive immune response in the body. At the same time, OMVs are derived from bacteria, which make it easy to modify. The methods by genetic engineering and others can improve their tumor targeting, give them new functions, or reduce their immunotoxicity, which is conducive to their application in tumor therapy. OMVs not only induce apoptosis or pyroptosis of tumor cells, but also regulate the host immune system, which makes OMVs themselves have a certain killing effect on tumors. In addition, the tendency of neutrophils to inflammatory tumor sites and the formation of neutrophil extracellular traps enable OMVs to target tumor sites, and the suitable size and the characteristic that they are easily taken up by DCs give OMVs a certain lymphatic targeting ability. Therefore, OMVs are often employed as excellent drug or vaccine carriers in tumor therapy. This review mainly discusses the biological mechanism of OMVs, the regulatory effects of OMVs on immune cells, the functional modification strategies of OMVs, and their research progress in tumor therapy.
